What O O O O
treatments O O O O
are O O O O
working O O O O
for O O O O
Covid-19? O O O O
From O O O O
existing O O O O
antivirals O O O O
to O O O O
new O O O O
antibody O O O O
therapies O O O O
- O O O O
researchers O O O O
are O O O O
working O O O O
tirelessly O O O O
to O O O O
find O O O O
the O O O O
best O O O O
drugs O O O O
to O O O O
treat O O O O
Covid-19. O O O O
So O O O O
far, O O O O
apart O O O O
from O O O O
clinical O O O O
care O O O O
and O O O O
oxygen, O O O O
only O O O O
a O O O O
few O O O O
drugs O O O O
have O O O O
proved O O O O
effective O O O O
at O O O O
treating O O O O
patients O O O O
with O O O O
Covid-19: O O O O
the Reason 4 O O
anti-inflammatories Reason 4 O O
dexamethasone Reason 4 O O
and Reason 4 O O
tocilizumab, Reason 4 O O
and Reason 4 O O
a Reason 4 O O
combination Reason 4 O O
of Reason 4 O O
monoclonal Reason 4 O O
antibodies Reason 4 O O
(casirivimab Reason 4 O O
and Reason 4 O O
imdevimab); Reason 4 O O
but Reason 4 O O
the Reason 4 O O
latter Reason 4 O O
only Reason 4 O O
works Reason 4 O O
in Reason 4 O O
patients Reason 4 O O
who Reason 4 O O
haven't Reason 4 O O
mounted Reason 4 O O
an Reason 4 O O
immune Reason 4 O O
response Reason 4 O O
to Reason 4 O O
the Reason 4 O O
virus Reason 4 O O
themselves. Reason 4 O O
The Reason 4 O O
search Reason 4 O O
for Reason 4 O O
safe Reason 4 O O
and Reason 4 O O
effective Reason 4 O O
treatments Reason 4 O O
must Reason 4 O O
continue. Reason 4 O O
Even Reason 4 O O
though Reason 4 O O
vaccination Reason 4 O O
is Reason 4 O O
underway Reason 4 O O
and Reason 4 O O
[more Reason 4 O O
than Reason 4 O O
2.5 Reason 4 O O
billion Reason 4 O O
vaccine Reason 4 O O
doses Reason 4 O O
have Reason 4 O O
been Reason 4 O O
given Reason 4 O O
so Reason 4 O O
far](https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/#global) Reason 4 O O
- Reason 4 O O
mostly Reason 4 O O
in Reason 4 O O
high-income Reason 4 O O
countries Reason 4 O O
- Reason 4 O O
Covid-19 Reason 4 O O
continues Reason 4 O O
to Reason 4 O O
spread Reason 4 O O
across Reason 4 O O
the Reason 4 O O
globe. Reason 4 O O
Teams Reason 4 O O
of Reason 4 O O
scientists Reason 4 O O
are Reason 4 O O
looking Reason 4 O O
into Reason 4 O O
[more Reason 4 O O
than Reason 4 O O
300 Reason 4 O O
potential Reason 4 O O
treatment Reason 4 O O
options](https://covid-19tracker.milkeninstitute.org/#treatment_antibodies), Reason 4 O O
running Reason 4 O O
[thousands Reason 4 O O
of Reason 4 O O
studies Reason 4 O O
around Reason 4 O O
the Reason 4 O O
world](https://covid-nma.com/). Reason 4 O O
What Reason 4 O O
are Reason 4 O O
the Reason 4 O O
main Reason 4 O O
approaches Reason 4 O O
for Reason 4 O O
Covid-19 Reason 4 O O
treatments? Reason 4 O O
Oxygen Reason 4 O O
Oxygen Reason 4 O O
is Reason 4 O O
one Reason 4 O O
of Reason 4 O O
the Reason 4 O O
essential Reason 4 O O
medicines Reason 4 O O
for Reason 4 O O
treating Reason 4 O O
patients Reason 4 O O
with Reason 4 O O
Covid-19. Reason 4 O O
As Reason 4 O O
the Reason 4 O O
SARS-CoV-2 Reason 4 O O
virus Reason 4 O O
attacks Reason 4 O O
the Reason 4 O O
lungs, Reason 4 O O
it Reason 4 O O
can Reason 4 O O
cause Reason 4 O O
pneumonia Reason 4 O O
and Reason 4 O O
hypoxaemia Reason 4 O O
(a Reason 4 O O
lack Reason 4 O O
of Reason 4 O O
oxygen Reason 4 O O
in Reason 4 O O
the Reason 4 O O
blood). Reason 4 O O
So Reason 4 O O
for Reason 4 O O
people Reason 4 O O
hospitalised Reason 4 O O
with Reason 4 O O
Covid-19, Reason 4 O O
oxygen Reason 4 O O
therapy Reason 4 O O
is Reason 4 O O
lifesaving. Reason 4 O O
But Reason 4 O O
low- Reason 4 O O
and Reason 4 O O
middle-income Reason 4 O O
countries Reason 4 O O
face Reason 4 O O
hurdles Reason 4 O O
in Reason 4 O O
getting Reason 4 O O
oxygen Reason 4 O O
to Reason 4 O O
patients Reason 4 O O
- Reason 4 O O
it's Reason 4 O O
expensive, Reason 4 O O
the Reason 4 O O
equipment Reason 4 O O
is Reason 4 O O
not Reason 4 O O
designed Reason 4 O O
for Reason 4 O O
use Reason 4 O O
in Reason 4 O O
low-resource Reason 4 O O
settings, Reason 4 O O
and Reason 4 O O
the Reason 4 O O
countries Reason 4 O O
lack Reason 4 O O
the Reason 4 O O
infrastructure Reason 4 O O
needed, Reason 4 O O
such Reason 4 O O
as Reason 4 O O
electricity Reason 4 O O
and Reason 4 O O
transport Reason 4 O O
networks. Reason 4 O O
Wellcome Reason 4 O O
is Reason 4 O O
co-leading Reason 4 O O
the Reason 4 O O
[Covid-19 Reason 4 O O
Oxygen Reason 4 O O
Emergency Reason 4 O O
Taskforce](https://www.who.int/news/item/25-02-2021-covid-19-oxygen-emergency-impacting-more-than-half-a-million-people-in-low--and-middle-income-countries-every-day-as-demand-surges) Reason 4 O O
with Reason 4 O O
Unitaid Reason 4 O O
to Reason 4 O O
facilitate Reason 4 O O
access Reason 4 O O
to Reason 4 O O
emergency Reason 4 O O
oxygen Reason 4 O O
in Reason 4 O O
low- Reason 4 O O
and Reason 4 O O
middle-income Reason 4 O O
countries. Reason 4 O O
As Reason 4 O O
well Reason 4 O O
as Reason 4 O O
making Reason 4 O O
oxygen Reason 4 O O
available Reason 4 O O
where Reason 4 O O
it's Reason 4 O O
needed, Reason 4 O O
more Reason 4 O O
treatment Reason 4 O O
options Reason 4 O O
are Reason 4 O O
essential Reason 4 O O
for Reason 4 O O
treating Reason 4 O O
people Reason 4 O O
with Reason 4 O O
Covid-19 Reason 4 O O
everywhere. Reason 4 O O
Researchers Reason 4 O O
are Reason 4 O O
taking Reason 4 O O
a Reason 4 O O
wide Reason 4 O O
range Reason 4 O O
of Reason 4 O O
approaches Reason 4 O O
to Reason 4 O O
find Reason 4 O O
effective Reason 4 O O
and Reason 4 O O
safe Reason 4 O O
drugs. Reason 4 O O
The Reason 4 O O
three Reason 4 O O
main Reason 4 O O
approaches Reason 4 O O
are: Reason 4 O O
antivirals, Reason 4 O O
anti-inflammatory Reason 4 O O
drugs Reason 4 O O
and Reason 4 O O
antibody Reason 4 O O
treatments. Reason 4 O O
Antivirals Reason 4 O O
Antiviral Reason 4 O O
drugs Reason 4 O O
work Reason 4 O O
by Reason 4 O O
preventing Reason 4 O O
a Reason 4 O O
virus Reason 4 O O
from Reason 4 O O
developing Reason 4 O O
inside Reason 4 O O
the Reason 4 O O
human Reason 4 O O
body. Reason 4 O O
Every Reason 4 O O
virus Reason 4 O O
is Reason 4 O O
different Reason 4 O O
and Reason 4 O O
attacks Reason 4 O O
cells Reason 4 O O
in Reason 4 O O
specific Reason 4 O O
ways, Reason 4 O O
and Reason 4 O O
the Reason 4 O O
antiviral Reason 4 O O
drugs Reason 4 O O
that Reason 4 O O
fight Reason 4 O O
them Reason 4 O O
off Reason 4 O O
are Reason 4 O O
specific Reason 4 O O
too. Reason 4 O O
Very Reason 4 O O
rarely Reason 4 O O
does Reason 4 O O
an Reason 4 O O
antiviral Reason 4 O O
built Reason 4 O O
for Reason 4 O O
one Reason 4 O O
virus Reason 4 O O
also Reason 4 O O
work Reason 4 O O
for Reason 4 O O
another. Reason 4 O O
But Reason 4 O O
it Reason 4 O O
can Reason 4 O O
happen: Reason 4 O O
for Reason 4 O O
example, Reason 4 O O
some Reason 4 O O
HIV Reason 4 O O
drugs Reason 4 O O
have Reason 4 O O
also Reason 4 O O
proved Reason 4 O O
effective Reason 4 O O
in Reason 4 O O
fighting Reason 4 O O
off Reason 4 O O
hepatitis Reason 4 O O
B. Reason 4 O O
While Reason 4 O O
several Reason 4 O O
antivirals Reason 4 O O
specific Reason 4 O O
to Reason 4 O O
Covid-19 Reason 4 O O
are Reason 4 O O
in Reason 4 O O
clinical Reason 4 O O
trials, Reason 4 O O
finding Reason 4 O O
one Reason 4 O O
that Reason 4 O O
works Reason 4 O O
will Reason 4 O O
take Reason 4 O O
time. Reason 4 O O
In Reason 4 O O
the Reason 4 O O
meantime, Reason 4 O O
researchers Reason 4 O O
are Reason 4 O O
hopeful Reason 4 O O
that Reason 4 O O
some Reason 4 O O
existing Reason 4 O O
antivirals, Reason 4 O O
whether Reason 4 O O
already Reason 4 O O
on Reason 4 O O
the Reason 4 O O
market Reason 4 O O
or Reason 4 O O
experimental, Reason 4 O O
could Reason 4 O O
have Reason 4 O O
some Reason 4 O O
useful Reason 4 O O
effect Reason 4 O O
against Reason 4 O O
SARS-CoV-2. Reason 4 O O
One Reason 4 O O
such Reason 4 O O
antiviral, Reason 4 O O
[molnupiravir, Reason 4 O O
](https://www.msd.com/news/msd-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderate/) Reason 4 O O
[has Reason 4 O O
been Reason 4 O O
](https://www.msd.com/news/msd-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderate/) Reason 4 O O
[found Reason 4 O O
to Reason 4 O O
cut Reason 4 O O
hospitalisations Reason 4 O O
and Reason 4 O O
deaths Reason 4 O O
by Reason 4 O O
half](https://www.msd.com/news/msd-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderate/), Reason 4 O O
if Reason 4 O O
taken Reason 4 O O
early Reason 4 O O
after Reason 4 O O
symptoms Reason 4 O O
develop. Reason 4 O O
While Reason 4 O O
most Reason 4 O O
Covid-19 Reason 4 O O
vaccines Reason 4 O O
target Reason 4 O O
the Reason 4 O O
spike Reason 4 O O
protein Reason 4 O O
on Reason 4 O O
the Reason 4 O O
outside Reason 4 O O
of Reason 4 O O
the Reason 4 O O
virus, Reason 4 O O
molnupiravir Reason 4 O O
works Reason 4 O O
by Reason 4 O O
targeting Reason 4 O O
an Reason 4 O O
enzyme Reason 4 O O
the Reason 4 O O
virus Reason 4 O O
uses Reason 4 O O
to Reason 4 O O
make Reason 4 O O
copies Reason 4 O O
of Reason 4 O O
itself. Reason 4 O O
If Reason 4 O O
authorised Reason 4 O O
by Reason 4 O O
regulators, Reason 4 O O
molnupiravir Reason 4 O O
would Reason 4 O O
be Reason 4 O O
the Reason 4 O O
first Reason 4 O O
oral Reason 4 O O
antiviral Reason 4 O O
medication Reason 4 O O
for Reason 4 O O
Covid-19. Reason 4 O O
Other Reason 4 O O
existing Reason 4 O O
antivirals Reason 4 O O
have Reason 4 O O
been Reason 4 O O
tested, Reason 4 O O
but Reason 4 O O
so Reason 4 O O
far Reason 4 O O
have Reason 4 O O
not Reason 4 O O
proved Reason 4 O O
to Reason 4 O O
be Reason 4 O O
effective Reason 4 O O
against Reason 4 O O
Covid-19. Reason 4 O O
Examples Reason 4 O O
include: Reason 4 O O
- Reason 4 O O
Remdesivir, Reason 1 O O
an Reason 1 O O
antiviral Reason 1 O O
tested Reason 1 O O
as Reason 1 O O
an Reason 1 O O
Ebola Reason 1 O O
treatment. Reason 1 O O
Although Reason 1 O O
it Reason 1 O O
has Reason 1 O O
been Reason 1 O O
authorised Reason 1 O O
for Reason 1 O O
emergency Reason 1 O O
use Reason 1 O O
in Reason 1 O O
some Reason 1 O O
countries, Reason 1 O O
the Reason 1 O O
WHO Reason 1 O O
Solidarity Reason 1 O O
Trial Reason 1 O O
showed Reason 1 O O
that Reason 1 O O
[remdesivir Reason 1 O O
does Reason 1 O O
not Reason 1 O O
reduce Reason 1 O O
the Reason 1 O O
risk Reason 1 O O
of Reason 1 O O
dying Reason 1 O O
of Reason 1 O O
Covid-19](https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments)or Reason 1 O O
the Reason 1 O O
length Reason 1 O O
of Reason 1 O O
time Reason 1 O O
patients Reason 1 O O
need Reason 1 O O
to Reason 1 O O
stay Reason 1 O O
in Reason 1 O O
hospital. Reason 1 O O
- Reason 1 O O
Hydroxychloroquine, Reason 1 O O
a Reason 1 O O
drug Reason 1 O O
used Reason 1 O O
to Reason 1 O O
treat Reason 1 O O
malaria Reason 1 O O
and Reason 1 O O
rheumatology Reason 1 O O
conditions. Reason 1 O O
After Reason 1 O O
receiving Reason 1 O O
high-profile Reason 1 O O
attention Reason 1 O O
in Reason 1 O O
the Reason 1 O O
media, Reason 1 O O
the Reason 1 O O
large-scale Reason 1 O O
RECOVERY Reason 1 O O
Trial Reason 1 O O
showed Reason 1 O O
that Reason 1 O O
[hydroxychloroquine Reason 1 O O
has Reason 1 O O
no Reason 1 O O
benefit Reason 1 O O
for Reason 1 O O
hospitalised Reason 1 O O
patients Reason 1 O O
with Reason 1 O O
Covid-19](https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19). Reason 1 O O
- Reason 1 O O
Lopinavir-ritonavir, Reason 1 O O
a Reason 1 O O
combination Reason 1 O O
of Reason 1 O O
antivirals Reason 1 O O
used Reason 1 O O
to Reason 1 O O
treat Reason 1 O O
HIV. Reason 1 O O
The Reason 1 O O
RECOVERY Reason 1 O O
Trial Reason 1 O O
showed Reason 1 O O
[it Reason 1 O O
had Reason 1 O O
no Reason 1 O O
clinical Reason 1 O O
benefit Reason 1 O O
for Reason 1 O O
Covid-19 Reason 1 O O
patients](https://www.recoverytrial.net/results/lopinavar-results). Reason 1 O O
These O O O O
results O O O O
were O O O O
disappointing, O O O O
but O O O O
it's O O O O
really O O O O
important O O O O
to O O O O
know O O O O
them, O O O O
so O O O O
researchers O O O O
and O O O O
clinicians O O O O
can O O O O
look O O O O
at O O O O
other O O O O
potential O O O O
treatments. O O O O
Another O O O O
drug O O O O
that O O O O
has O O O O
been O O O O
gaining O O O O
visibility O O O O
for O O O O
its O O O O
potential O O O O
to O O O O
treat O O O O
Covid-19 O O O O
is O O O O
ivermectin O O O O
- O O O O
not O O O O
an O O O O
antiviral, O O O O
but O O O O
an O O O O
anti-parasitic O O O O
drug O O O O
used O O O O
to O O O O
treat O O O O
diseases O O O O
caused O O O O
by O O O O
parasitic O O O O
worms. O O O O
The O O O O
World O O O O
Health O O O O
Organization O O O O
(WHO) O O O O
recommends O O O O
that O O O O
ivermectin O O O O
should O O O O
not O O O O
be O O O O
used O O O O
to O O O O
treat O O O O
Covid-19 O O O O
outside O O O O
of O O O O
clinical O O O O
trials O O O O
because O O O O
there O O O O
isn't O O O O
enough O O O O
evidence O O O O
about O O O O
its O O O O
benefits. O O O O
One O O O O
such O O O O
trial O O O O
is O O O O
[Oxford's O O O O
PRINCIPLE O O O O
trial O O O O
in O O O O
the O O O O
UK](https://www.principletrial.org/news/ivermectin-to-be-investigated-as-a-possible-treatment-for-covid-19-in-oxford2019s-principle-trial), O O O O
which O O O O
is O O O O
looking O O O O
to O O O O
see O O O O
if O O O O
the O O O O
drug O O O O
helps O O O O
people O O O O
over-50 O O O O
with O O O O
Covid-19 O O O O
symptoms. O O O O
Anti-inflammatory O O O O
drugs O O O O
work O O O O
by O O O O
calming O O O O
the O O O O
immune O O O O
system. O O O O
In O O O O
people O O O O
with O O O O
severe O O O O
Covid-19, O O O O
the O O O O
body's O O O O
violent O O O O
reaction O O O O
in O O O O
trying O O O O
to O O O O
fight O O O O
off O O O O
the O O O O
virus O O O O
can O O O O
cause O O O O
serious O O O O
harm O O O O
and O O O O
even O O O O
death. O O O O
Anti-inflammatories O O O O
can O O O O
reduce O O O O
this O O O O
response. O O O O
Researchers O O O O
have O O O O
found O O O O
both O O O O
positive O O O O
and O O O O
negative O O O O
results. O O O O
They O O O O
have O O O O
looked O O O O
at: O O O O
- O O O O
Dexamethasone, O O O O
a O O O O
type O O O O
of O O O O
steroid O O O O
used O O O O
to O O O O
reduce O O O O
inflammation O O O O
in O O O O
a O O O O
range O O O O
of O O O O
conditions, O O O O
including Reason 5 O O
sore Reason 5 O O
throats. Reason 5 O O
This Reason 5 O O
was Reason 5 O O
[the Reason 5 O O
first Reason 5 O O
drug Reason 5 O O
to Reason 5 O O
be Reason 5 O O
shown Reason 5 O O
to Reason 5 O O
be Reason 5 O O
effective Reason 5 O O
in Reason 5 O O
reducing Reason 5 O O
death Reason 5 O O
rates](https://www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratory-complications-of-covid-19)- Reason 5 O O
by Reason 5 O O
up Reason 5 O O
to Reason 5 O O
one Reason 5 O O
third Reason 5 O O
in Reason 5 O O
hospitalised Reason 5 O O
patients Reason 5 O O
with Reason 5 O O
severe Reason 5 O O
respiratory Reason 5 O O
complications Reason 5 O O
of Reason 5 O O
Covid-19, Reason 5 O O
according Reason 5 O O
to Reason 5 O O
the Reason 5 O O
RECOVERY Reason 5 O O
Trial. Reason 5 O O
- Reason 5 O O
Tocilizumab, Reason 5 O O
an Reason 5 O O
intravenous Reason 5 O O
drug Reason 5 O O
used Reason 5 O O
to Reason 5 O O
treat Reason 5 O O
rheumatoid Reason 5 O O
arthritis. Reason 5 O O
The Reason 5 O O
RECOVERY Reason 5 O O
Trial Reason 5 O O
showed Reason 5 O O
[it Reason 5 O O
reduces Reason 5 O O
the Reason 5 O O
risk Reason 5 O O
of Reason 5 O O
death Reason 5 O O
when Reason 5 O O
given Reason 5 O O
to Reason 5 O O
hospitalised Reason 5 O O
patients](https://www.recoverytrial.net/news/tocilizumab-reduces-deaths-in-patients-hospitalised-with-covid-19)with Reason 5 O O
severe Reason 5 O O
Covid-19, Reason 5 O O
and Reason 5 O O
it Reason 5 O O
shortens Reason 5 O O
the Reason 5 O O
time Reason 5 O O
they Reason 5 O O
spend Reason 5 O O
in Reason 5 O O
the Reason 5 O O
hospital. Reason 5 O O
- Reason 5 O O
Interferon Reason 5 O O
beta-1a, Reason 5 O O
used Reason 5 O O
to Reason 5 O O
treat Reason 5 O O
multiple Reason 5 O O
sclerosis Reason 5 O O
by Reason 5 O O
stopping Reason 5 O O
the Reason 5 O O
immune Reason 5 O O
system Reason 5 O O
from Reason 5 O O
damaging Reason 5 O O
the Reason 5 O O
coatings Reason 5 O O
of Reason 5 O O
nerve Reason 5 O O
cells. Reason 5 O O
Interferons Reason 5 O O
have Reason 5 O O
previously Reason 5 O O
been Reason 5 O O
found Reason 5 O O
to Reason 5 O O
show Reason 5 O O
some Reason 5 O O
effects Reason 5 O O
against Reason 5 O O
MERS-CoV Reason 5 O O
and Reason 5 O O
SARS, Reason 5 O O
which Reason 5 O O
are Reason 5 O O
also Reason 5 O O
caused Reason 5 O O
by Reason 5 O O
coronaviruses, Reason 5 O O
but Reason 5 O O
the Reason 5 O O
WHO Reason 5 O O
Solidarity Reason 5 O O
Trial Reason 5 O O
showed Reason 5 O O
that Reason 5 O O
[it Reason 5 O O
had Reason 5 O O
little Reason 5 O O
or Reason 5 O O
no Reason 5 O O
effect Reason 5 O O
on Reason 5 O O
Covid-19 Reason 5 O O
patients](https://www.who.int/news/item/15-10-2020-solidarity-therapeutics-trial-produces-conclusive-evidence-on-the-effectiveness-of-repurposed-drugs-for-covid-19-in-record-time). Reason 5 O O
Antibodies Reason 5 O O
attack Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
directly. Reason 5 O O
Unlike Reason 5 O O
antivirals Reason 5 O O
and Reason 5 O O
anti-inflammatory Reason 5 O O
drugs, Reason 5 O O
antibodies Reason 5 O O
are Reason 5 O O
produced Reason 5 O O
naturally Reason 5 O O
by Reason 5 O O
people Reason 5 O O
who Reason 5 O O
have Reason 5 O O
had Reason 5 O O
an Reason 5 O O
infection Reason 5 O O
and Reason 5 O O
recovered. Reason 5 O O
When Reason 5 O O
given Reason 5 O O
to Reason 5 O O
patients Reason 5 O O
who Reason 5 O O
are Reason 5 O O
fighting Reason 5 O O
off Reason 5 O O
an Reason 5 O O
infection, Reason 5 O O
antibodies Reason 5 O O
can Reason 5 O O
boost Reason 5 O O
their Reason 5 O O
immune Reason 5 O O
response Reason 5 O O
and Reason 5 O O
stop Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
from Reason 5 O O
causing Reason 5 O O
further Reason 5 O O
harm. Reason 5 O O
There Reason 5 O O
are Reason 5 O O
two Reason 5 O O
ways Reason 5 O O
that Reason 5 O O
antibodies Reason 5 O O
can Reason 5 O O
be Reason 5 O O
used: Reason 5 O O
- Reason 5 O O
Convalescent Reason 5 O O
plasma Reason 5 O O
can Reason 5 O O
be Reason 5 O O
extracted Reason 5 O O
from Reason 5 O O
the Reason 5 O O
blood Reason 5 O O
of Reason 5 O O
Covid-19 Reason 5 O O
survivors Reason 5 O O
and Reason 5 O O
injected Reason 5 O O
into Reason 5 O O
patients Reason 5 O O
who Reason 5 O O
are Reason 5 O O
fighting Reason 5 O O
the Reason 5 O O
disease. Reason 5 O O
This Reason 5 O O
was Reason 5 O O
widely Reason 5 O O
used Reason 5 O O
as Reason 5 O O
a Reason 5 O O
treatment Reason 5 O O
around Reason 5 O O
the Reason 5 O O
world Reason 5 O O
at Reason 5 O O
the Reason 5 O O
start Reason 5 O O
of Reason 5 O O
the Reason 5 O O
pandemic, Reason 5 O O
but Reason 5 O O
the Reason 5 O O
RECOVERY Reason 5 O O
Trial Reason 5 O O
[found Reason 5 O O
no Reason 5 O O
convincing Reason 5 O O
evidence Reason 5 O O
of Reason 5 O O
its Reason 5 O O
effect](https://www.recoverytrial.net/news/statement-from-the-recovery-trial-chief-investigators-15-january-2021-recovery-trial-closes-recruitment-to-convalescent-plasma-treatment-for-patients-hospitalised-with-covid-19). Reason 5 O O
[Monoclonal Reason 3 O O
antibodies](/news/what-are-monoclonal-antibodies-can-they-treat-covid-19)are Reason 3 O O
antibodies Reason 3 O O
specific Reason 3 O O
to Reason 3 O O
Covid-19. Reason 3 O O
While Reason 3 O O
they Reason 3 O O
also Reason 3 O O
originate Reason 3 O O
in Reason 3 O O
the Reason 3 O O
blood Reason 3 O O
of Reason 3 O O
people Reason 3 O O
who Reason 3 O O
have Reason 3 O O
recovered, Reason 3 O O
that Reason 3 O O
is Reason 3 O O
only Reason 3 O O
the Reason 3 O O
starting Reason 3 O O
point. Reason 3 O O
Scientists Reason 3 O O
select Reason 3 O O
the Reason 3 O O
relevant Reason 3 O O
antibodies, Reason 3 O O
extract Reason 3 O O
and Reason 3 O O
expand Reason 3 O O
them, Reason 3 O O
and Reason 3 O O
then Reason 3 O O
manufacture Reason 3 O O
them Reason 3 O O
in Reason 3 O O
large Reason 3 O O
quantities. Reason 3 O O
A Reason 3 O O
combination Reason 3 O O
of Reason 3 O O
monoclonal Reason 3 O O
antibodies Reason 3 O O
produced Reason 3 O O
by Reason 3 O O
Regeneron Reason 3 O O
(casirivimab Reason 3 O O
and Reason 3 O O
imdevimab) Reason 3 O O
is Reason 3 O O
[the Reason 3 O O
first Reason 3 O O
therapy Reason 3 O O
specific Reason 3 O O
to Reason 3 O O
Covid-19 Reason 3 O O
that Reason 3 O O
was Reason 3 O O
proved Reason 3 O O
to Reason 3 O O
reduce Reason 3 O O
deaths](https://www.recoverytrial.net/news/recovery-trial-finds-regeneron2019s-monoclonal-antibody-combination-reduces-deaths-for-hospitalised-covid-19-patients-who-have-not-mounted-their-own-immune-response-1)- Reason 3 O O
but Reason 3 O O
only Reason 3 O O
in Reason 3 O O
hospitalised Reason 3 O O
patients Reason 3 O O
who Reason 3 O O
haven't Reason 3 O O
mounted Reason 3 O O
a Reason 3 O O
natural Reason 3 O O
antibody Reason 3 O O
response Reason 3 O O
of Reason 3 O O
their Reason 3 O O
own, Reason 3 O O
as Reason 3 O O
the Reason 3 O O
RECOVERY Reason 3 O O
trial Reason 3 O O
showed. Reason 3 O O
However, O O O O
[monoclonal O O O O
antibodies O O O O
are O O O O
typically O O O O
very O O O O
expensive](/news/more-people-should-have-access-monoclonal-antibodies-covid-19-can-make-happen)and O O O O
not O O O O
widely O O O O
available O O O O
across O O O O
the O O O O
world. O O O O
Covid-19 O O O O
could O O O O
be O O O O
the O O O O
catalyst O O O O
to O O O O
change O O O O
that, O O O O
so O O O O
these O O O O
treatments O O O O
become O O O O
more O O O O
affordable O O O O
and O O O O
accessible O O O O
to O O O O
people O O O O
in O O O O
rich O O O O
and O O O O
poor O O O O
countries O O O O
alike. O O O O
Antidepressants O O O O
Selective O O O O
serotonin O O O O
reuptake O O O O
inhibitors O O O O
(SSRI) O O O O
Selective O O O O
serotonin O O O O
reuptake O O O O
inhibitors O O O O
(SSRIs) O O O O
are O O O O
a O O O O
widely O O O O
used O O O O
type O O O O
of O O O O
antidepressant. O O O O
Mainly O O O O
prescribed O O O O
to O O O O
treat O O O O
depression, O O O O
particularly O O O O
persistent O O O O
or O O O O
severe O O O O
cases, O O O O
many O O O O
antidepressants O O O O
have O O O O
been O O O O
found O O O O
to O O O O
have O O O O
anti-inflammatory O O O O
properties. O O O O
There O O O O
are O O O O
ongoing O O O O
studies O O O O
to O O O O
find O O O O
if O O O O
any O O O O
SSRI's O O O O
could O O O O
be O O O O
used O O O O
as O O O O
potential O O O O
treatments O O O O
for O O O O
Covid-19. O O O O
[The Reason 3 O O
results Reason 3 O O
of Reason 3 O O
a Reason 3 O O
new Reason 3 O O
randomised Reason 3 O O
clinical Reason 3 O O
trial Reason 3 O O
have Reason 3 O O
indicated Reason 3 O O
that Reason 3 O O
using Reason 3 O O
fluvoxamine Reason 3 O O
to Reason 3 O O
treat Reason 3 O O
high-risk Reason 3 O O
outpatients Reason 3 O O
with Reason 3 O O
early-diagnosed Reason 3 O O
Covid-19](https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00448-4/fulltext) Reason 3 O O
reduced Reason 3 O O
the Reason 3 O O
need Reason 3 O O
for Reason 3 O O
prolonged Reason 3 O O
observation Reason 3 O O
in Reason 3 O O
an Reason 3 O O
emergency Reason 3 O O
setting Reason 3 O O
or Reason 3 O O
hospitalisation, Reason 3 O O
compared Reason 3 O O
to Reason 3 O O
a Reason 3 O O
control Reason 3 O O
group Reason 3 O O
who Reason 3 O O
received Reason 3 O O
a Reason 3 O O
placebo. Reason 3 O O
While Reason 3 O O
this Reason 3 O O
shows Reason 3 O O
promise, Reason 3 O O
more Reason 3 O O
research Reason 3 O O
and Reason 3 O O
clinical Reason 3 O O
trial Reason 3 O O
data Reason 3 O O
is Reason 3 O O
needed Reason 3 O O
on Reason 3 O O
SSRIs Reason 3 O O
as Reason 3 O O
a Reason 3 O O
Covid-19 Reason 3 O O
treatment. Reason 3 O O
How Reason 3 O O
do Reason 3 O O
we Reason 3 O O
find Reason 3 O O
out Reason 3 O O
whether Reason 3 O O
treatments Reason 3 O O
work? Reason 3 O O
Potential Reason 3 O O
new Reason 3 O O
drugs Reason 3 O O
usually Reason 3 O O
have Reason 3 O O
to Reason 3 O O
go Reason 3 O O
through Reason 3 O O
years Reason 3 O O
of Reason 3 O O
laboratory Reason 3 O O
work, Reason 3 O O
animal Reason 3 O O
testing Reason 3 O O
and Reason 3 O O
human Reason 3 O O
clinical Reason 3 O O
trials Reason 3 O O
before Reason 3 O O
they're Reason 3 O O
proved Reason 3 O O
to Reason 3 O O
be Reason 3 O O
safe Reason 3 O O
and Reason 3 O O
effective Reason 3 O O
against Reason 3 O O
a Reason 3 O O
specific Reason 3 O O
disease. Reason 3 O O
This Reason 3 O O
is Reason 3 O O
why Reason 3 O O
researchers Reason 3 O O
have Reason 3 O O
first Reason 3 O O
been Reason 3 O O
looking Reason 3 O O
into Reason 3 O O
existing Reason 3 O O
drugs, Reason 3 O O
some Reason 3 O O
experimental Reason 3 O O
and Reason 3 O O
some Reason 3 O O
already Reason 3 O O
licensed, Reason 3 O O
that Reason 3 O O
were Reason 3 O O
developed Reason 3 O O
for Reason 3 O O
other Reason 3 O O
infections, Reason 3 O O
such Reason 3 O O
as Reason 3 O O
Ebola Reason 3 O O
and Reason 3 O O
malaria. Reason 3 O O
These Reason 3 O O
drugs Reason 3 O O
have Reason 3 O O
a Reason 3 O O
head Reason 3 O O
start Reason 3 O O
and Reason 3 O O
we Reason 3 O O
can Reason 3 O O
establish Reason 3 O O
more Reason 3 O O
quickly Reason 3 O O
whether Reason 3 O O
they Reason 3 O O
are Reason 3 O O
useful Reason 3 O O
against Reason 3 O O
Covid-19. Reason 3 O O
Experimental Reason 3 O O
drugs, Reason 3 O O
such Reason 3 O O
as Reason 3 O O
remdesivir, Reason 3 O O
may Reason 3 O O
have Reason 3 O O
already Reason 3 O O
been Reason 3 O O
tested Reason 3 O O
in Reason 3 O O
animals Reason 3 O O
for Reason 3 O O
safety. Reason 3 O O
But Reason 3 O O
they Reason 3 O O
usually Reason 3 O O
have Reason 3 O O
to Reason 3 O O
go Reason 3 O O
through Reason 3 O O
safety Reason 3 O O
trials Reason 3 O O
in Reason 3 O O
humans, Reason 3 O O
to Reason 3 O O
assess Reason 3 O O
what Reason 3 O O
the Reason 3 O O
safe Reason 3 O O
dose Reason 3 O O
is, Reason 3 O O
before Reason 3 O O
moving Reason 3 O O
into Reason 3 O O
clinical Reason 3 O O
trials Reason 3 O O
to Reason 3 O O
assess Reason 3 O O
how Reason 3 O O
effective Reason 3 O O
they Reason 3 O O
are. Reason 3 O O
Existing Reason 3 O O
antivirals Reason 3 O O
have Reason 3 O O
already Reason 3 O O
been Reason 3 O O
proved Reason 3 O O
to Reason 3 O O
be Reason 3 O O
safe Reason 3 O O
for Reason 3 O O
humans, Reason 3 O O
at Reason 3 O O
a Reason 3 O O
specific Reason 3 O O
dose, Reason 3 O O
so Reason 3 O O
what Reason 3 O O
needs Reason 3 O O
to Reason 3 O O
be Reason 3 O O
done Reason 3 O O
next Reason 3 O O
is Reason 3 O O
test Reason 3 O O
whether Reason 3 O O
they Reason 3 O O
work Reason 3 O O
in Reason 3 O O
people Reason 3 O O
with Reason 3 O O
Covid-19. Reason 3 O O
Only Reason 3 O O
large Reason 3 O O
randomised Reason 3 O O
controlled Reason 3 O O
trials, Reason 3 O O
with Reason 3 O O
hundreds Reason 3 O O
or Reason 3 O O
thousands Reason 3 O O
of Reason 3 O O
people Reason 3 O O
enrolled Reason 3 O O
across Reason 3 O O
the Reason 3 O O
world, Reason 3 O O
can Reason 3 O O
tell Reason 3 O O
us Reason 3 O O
whether Reason 3 O O
existing Reason 3 O O
antivirals Reason 3 O O
bring Reason 3 O O
benefits Reason 3 O O
to Reason 3 O O
people Reason 3 O O
with Reason 3 O O
Covid-19. Reason 3 O O
Existing Reason 3 O O
anti-inflammatory Reason 3 O O
drugs Reason 3 O O
are Reason 3 O O
also Reason 3 O O
already Reason 3 O O
known Reason 3 O O
to Reason 3 O O
be Reason 3 O O
safe Reason 3 O O
if Reason 3 O O
used Reason 3 O O
in Reason 3 O O
certain Reason 3 O O
ways. Reason 3 O O
But Reason 3 O O
because Reason 3 O O
of Reason 3 O O
the Reason 3 O O
way Reason 3 O O
these Reason 3 O O
drugs Reason 3 O O
interact Reason 3 O O
with Reason 3 O O
the Reason 3 O O
immune Reason 3 O O
system, Reason 3 O O
we Reason 3 O O
need Reason 3 O O
more Reason 3 O O
data Reason 3 O O
to Reason 3 O O
understand Reason 3 O O
whether Reason 3 O O
they Reason 3 O O
are Reason 3 O O
safe Reason 3 O O
in Reason 3 O O
the Reason 3 O O
context Reason 3 O O
of Reason 3 O O
a Reason 3 O O
Covid-19 Reason 3 O O
infection. Reason 3 O O
This Reason 3 O O
can Reason 3 O O
be Reason 3 O O
done Reason 3 O O
through Reason 3 O O
small Reason 3 O O
studies Reason 3 O O
first, Reason 3 O O
to Reason 3 O O
assess Reason 3 O O
what Reason 3 O O
the Reason 3 O O
right Reason 3 O O
dose Reason 3 O O
is, Reason 3 O O
before Reason 3 O O
moving Reason 3 O O
into Reason 3 O O
large Reason 3 O O
randomised Reason 3 O O
controlled Reason 3 O O
studies Reason 3 O O
to Reason 3 O O
test Reason 3 O O
their Reason 3 O O
effectiveness. Reason 3 O O
Monoclonal Reason 3 O O
antibodies Reason 3 O O
are Reason 3 O O
a Reason 3 O O
new Reason 3 O O
potential Reason 3 O O
treatment, Reason 3 O O
so Reason 3 O O
they Reason 3 O O
also Reason 3 O O
have Reason 3 O O
to Reason 3 O O
go Reason 3 O O
through Reason 3 O O
safety Reason 3 O O
trials Reason 3 O O
in Reason 3 O O
humans. Reason 3 O O
But Reason 3 O O
because Reason 3 O O
these Reason 3 O O
are Reason 3 O O
natural Reason 3 O O
antibodies Reason 3 O O
originating Reason 3 O O
in Reason 3 O O
human Reason 3 O O
bodies, Reason 3 O O
not Reason 3 O O
synthetic Reason 3 O O
compounds, Reason 3 O O
safety Reason 3 O O
trials Reason 3 O O
will Reason 3 O O
take Reason 3 O O
less Reason 3 O O
time Reason 3 O O
to Reason 3 O O
conduct. Reason 3 O O
After Reason 3 O O
that, Reason 3 O O
effectiveness Reason 3 O O
studies Reason 3 O O
can Reason 3 O O
get Reason 3 O O
going. Reason 3 O O
Large Reason 3 O O
randomised Reason 3 O O
clinical Reason 3 O O
trials Reason 3 O O
- Reason 3 O O
such Reason 3 O O
as Reason 3 O O
the Reason 3 O O
[WHO's Reason 3 O O
Solidarity Reason 3 O O
clinical Reason 3 O O
trial](https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments) Reason 3 O O
and Reason 3 O O
the Reason 3 O O
[UK's Reason 3 O O
RECOVERY Reason 3 O O
Trial](https://www.recoverytrial.net/) Reason 3 O O
- Reason 3 O O
are Reason 3 O O
essential Reason 3 O O
for Reason 3 O O
getting Reason 3 O O
robust Reason 3 O O
data Reason 3 O O
about Reason 3 O O
which Reason 3 O O
treatments Reason 3 O O
work Reason 3 O O
against Reason 3 O O
Covid-19. Reason 3 O O
These Reason 3 O O
studies Reason 3 O O
are Reason 3 O O
designed Reason 3 O O
to Reason 3 O O
be Reason 3 O O
adaptable Reason 3 O O
ongoing Reason 3 O O
platforms, Reason 3 O O
so Reason 3 O O
they Reason 3 O O
can Reason 3 O O
quickly Reason 3 O O
stop Reason 3 O O
testing Reason 3 O O
drugs Reason 3 O O
that Reason 3 O O
prove Reason 3 O O
not Reason 3 O O
to Reason 3 O O
be Reason 3 O O
working, Reason 3 O O
and Reason 3 O O
add Reason 3 O O
new Reason 3 O O
ones Reason 3 O O
as Reason 3 O O
they Reason 3 O O
develop. Reason 3 O O
The Reason 3 O O
nature Reason 3 O O
of Reason 3 O O
of Reason 3 O O
Covid-19 Reason 3 O O
is Reason 3 O O
that Reason 3 O O
we Reason 3 O O
need Reason 3 O O
drugs. Reason 3 O O
We Reason 3 O O
need Reason 3 O O
drugs Reason 3 O O
which Reason 3 O O
we Reason 3 O O
know Reason 3 O O
work Reason 3 O O
and Reason 3 O O
we Reason 3 O O
need Reason 3 O O
them Reason 3 O O
as Reason 3 O O
soon Reason 3 O O
as Reason 3 O O
possible. Reason 3 O O
Covid-19 Reason 3 O O
treatments: Reason 3 O O
inside Reason 3 O O
the Reason 3 O O
world's Reason 3 O O
largest Reason 3 O O
clinical Reason 3 O O
trial Reason 3 O O
for Reason 3 O O
Covid-19 Reason 3 O O
Professor Reason 3 O O
Martin Reason 3 O O
Landray, Reason 3 O O
Nuffield Reason 3 O O
Department Reason 3 O O
of Reason 3 O O
Population Reason 3 O O
Health, Reason 3 O O
University Reason 3 O O
of Reason 3 O O
Oxford: Reason 3 O O
"For Reason 3 O O
patients Reason 3 O O
that Reason 3 O O
are Reason 3 O O
admitted Reason 3 O O
to Reason 3 O O
hospital Reason 3 O O
with Reason 3 O O
Covid-19, Reason 3 O O
then Reason 3 O O
typically, Reason 3 O O
one Reason 3 O O
in Reason 3 O O
five Reason 3 O O
will Reason 3 O O
sadly Reason 3 O O
die, Reason 3 O O
so Reason 3 O O
actually Reason 3 O O
saving Reason 3 O O
lives Reason 3 O O
is Reason 3 O O
the Reason 3 O O
key Reason 3 O O
thing Reason 3 O O
we're Reason 3 O O
looking Reason 3 O O
for. Reason 3 O O
The Reason 3 O O
Recovery Reason 3 O O
Trial Reason 3 O O
was Reason 3 O O
set Reason 3 O O
up Reason 3 O O
at Reason 3 O O
record Reason 3 O O
speed. Reason 3 O O
It Reason 3 O O
had Reason 3 O O
to Reason 3 O O
be, Reason 3 O O
we Reason 3 O O
know Reason 3 O O
it Reason 3 O O
had Reason 3 O O
to Reason 3 O O
be. Reason 3 O O
We Reason 3 O O
had Reason 3 O O
to Reason 3 O O
set Reason 3 O O
this Reason 3 O O
trial Reason 3 O O
up Reason 3 O O
within Reason 3 O O
two Reason 3 O O
weeks. Reason 3 O O
Well, Reason 3 O O
we Reason 3 O O
beat Reason 3 O O
that Reason 3 O O
and Reason 3 O O
we Reason 3 O O
set Reason 3 O O
it Reason 3 O O
up Reason 3 O O
within Reason 3 O O
nine Reason 3 O O
days. Reason 3 O O
That Reason 3 O O
is Reason 3 O O
a Reason 3 O O
speed Reason 3 O O
and Reason 3 O O
scale Reason 3 O O
that Reason 3 O O
has Reason 3 O O
never Reason 3 O O
been Reason 3 O O
matched Reason 3 O O
in Reason 3 O O
any Reason 3 O O
setting, Reason 3 O O
let Reason 3 O O
alone Reason 3 O O
in Reason 3 O O
the Reason 3 O O
context Reason 3 O O
of Reason 3 O O
a Reason 3 O O
pandemic. Reason 3 O O
We're Reason 3 O O
studying Reason 3 O O
four Reason 3 O O
or Reason 3 O O
five Reason 3 O O
drugs Reason 3 O O
simultaneously. Reason 3 O O
And Reason 3 O O
as Reason 3 O O
we Reason 3 O O
get Reason 3 O O
enough Reason 3 O O
evidence Reason 3 O O
that Reason 3 O O
one Reason 3 O O
drug Reason 3 O O
is Reason 3 O O
definitely Reason 3 O O
useful, Reason 3 O O
or Reason 3 O O
perhaps Reason 3 O O
not Reason 3 O O
so Reason 3 O O
useful, Reason 3 O O
we Reason 3 O O
can Reason 3 O O
stop Reason 3 O O
studying Reason 3 O O
that Reason 3 O O
drug Reason 3 O O
and Reason 3 O O
move Reason 3 O O
on Reason 3 O O
and Reason 3 O O
slot Reason 3 O O
in Reason 3 O O
other Reason 3 O O
drugs Reason 3 O O
as Reason 3 O O
they Reason 3 O O
become Reason 3 O O
available. Reason 3 O O
To Reason 3 O O
date, Reason 3 O O
there Reason 3 O O
are Reason 3 O O
just Reason 3 O O
over Reason 3 O O
10,000 Reason 3 O O
patients Reason 3 O O
who've Reason 3 O O
enrolled Reason 3 O O
in Reason 3 O O
the Reason 3 O O
clinical Reason 3 O O
trial. Reason 3 O O
Roughly Reason 3 O O
speaking, Reason 3 O O
that's Reason 3 O O
about Reason 3 O O
13 Reason 3 O O
or Reason 3 O O
14% Reason 3 O O
of Reason 3 O O
all Reason 3 O O
patients Reason 3 O O
who've Reason 3 O O
been Reason 3 O O
admitted Reason 3 O O
to Reason 3 O O
hospital Reason 3 O O
within Reason 3 O O
the Reason 3 O O
UK, Reason 3 O O
which Reason 3 O O
I Reason 3 O O
think Reason 3 O O
in Reason 3 O O
itself Reason 3 O O
is Reason 3 O O
something Reason 3 O O
of Reason 3 O O
a Reason 3 O O
record. Reason 3 O O
I Reason 3 O O
mean, Reason 3 O O
the Reason 3 O O
collaboration Reason 3 O O
has Reason 3 O O
been Reason 3 O O
colossal Reason 3 O O
from Reason 3 O O
different Reason 3 O O
parts Reason 3 O O
of Reason 3 O O
the Reason 3 O O
system. Reason 3 O O
From Reason 3 O O
within Reason 3 O O
the Reason 3 O O
UK, Reason 3 O O
the Reason 3 O O
Department Reason 3 O O
of Reason 3 O O
Health, Reason 3 O O
from Reason 3 O O
the Reason 3 O O
regulatory Reason 3 O O
agency, Reason 3 O O
the Reason 3 O O
MHRA, Reason 3 O O
from Reason 3 O O
the Reason 3 O O
ethics Reason 3 O O
committee, Reason 3 O O
from Reason 3 O O
the Reason 3 O O
research Reason 3 O O
infrastructure Reason 3 O O
on Reason 3 O O
the Reason 3 O O
ground, Reason 3 O O
coordinated Reason 3 O O
from Reason 3 O O
the Reason 3 O O
team Reason 3 O O
at Reason 3 O O
University Reason 3 O O
of Reason 3 O O
Oxford. Reason 3 O O
But Reason 3 O O
this Reason 3 O O
is Reason 3 O O
not Reason 3 O O
about Reason 3 O O
any Reason 3 O O
one Reason 3 O O
person Reason 3 O O
or Reason 3 O O
organisation. Reason 3 O O
This Reason 3 O O
is Reason 3 O O
about Reason 3 O O
teamwork Reason 3 O O
and Reason 3 O O
that's Reason 3 O O
what Reason 3 O O
matters." Reason 3 O O
We Reason 3 O O
must Reason 3 O O
continue Reason 3 O O
to Reason 3 O O
fund Reason 3 O O
large-scale Reason 3 O O
trials Reason 3 O O
across Reason 3 O O
the Reason 3 O O
world Reason 3 O O
to Reason 3 O O
find Reason 3 O O
treatments Reason 3 O O
for Reason 3 O O
Covid-19. Reason 3 O O
How O O O O
do O O O O
we O O O O
make O O O O
Covid-19 O O O O
treatments O O O O
accessible O O O O
to O O O O
all? O O O O
Covid-19 O O O O
has O O O O
reached O O O O
every O O O O
corner O O O O
of O O O O
the O O O O
world, O O O O
and O O O O
it O O O O
will O O O O
keep O O O O
spreading O O O O
unless O O O O
it O O O O
is O O O O
controlled O O O O
everywhere. O O O O
To O O O O
stop O O O O
the O O O O
pandemic, O O O O
to O O O O
get O O O O
societies O O O O
back O O O O
to O O O O
normal, O O O O
and O O O O
to O O O O
get O O O O
economies O O O O
moving O O O O
again, O O O O
any O O O O
[treatments O O O O
and O O O O
vaccines O O O O
must O O O O
be O O O O
made O O O O
accessible O O O O
to O O O O
everyone](/what-we-do/our-work/coronavirus-covid-19/access) O O O O
who O O O O
needs O O O O
them, O O O O
everywhere O O O O
in O O O O
the O O O O
world, O O O O
regardless O O O O
of O O O O
their O O O O
ability O O O O
to O O O O
pay. O O O O
For O O O O
that O O O O
to O O O O
happen: O O O O
- O O O O
governments, O O O O
industry O O O O
and O O O O
philanthropy O O O O
must O O O O
pool O O O O
resources O O O O
to O O O O
pay O O O O
for O O O O
the O O O O
risk, O O O O
the O O O O
research, O O O O
manufacturing O O O O
and O O O O
distribution O O O O
to O O O O
ensure O O O O
everyone O O O O
has O O O O
access O O O O
to O O O O
treatments O O O O
- O O O O
clinical O O O O
trials O O O O
need O O O O
to O O O O
take O O O O
place O O O O
across O O O O
the O O O O
world, O O O O
to O O O O
make O O O O
sure O O O O
treatments O O O O
work O O O O
for O O O O
everyone O O O O
- O O O O
national O O O O
governments O O O O
must O O O O
work O O O O
together O O O O
to O O O O
ensure O O O O
that O O O O
coronavirus O O O O
treatments O O O O
can O O O O
be O O O O
manufactured O O O O
in O O O O
as O O O O
many O O O O
countries O O O O
as O O O O
possible O O O O
and O O O O
distributed O O O O
globally O O O O
to O O O O
everyone O O O O
who O O O O
needs O O O O
them. O O O O
Global O O O O
collaboration O O O O
is O O O O
paramount O O O O
for O O O O
ensuring O O O O
global O O O O
access O O O O
to O O O O
treatments. O O O O
To O O O O
promote O O O O
this, O O O O
the O O O O
ACT-Accelerator O O O O
was O O O O
launched. O O O O
Through O O O O
this O O O O
collaboration, O O O O
the O O O O
World O O O O
Health O O O O
Organization, O O O O
governments O O O O
and O O O O
international O O O O
health O O O O
bodies O O O O
have O O O O
pledged O O O O
to O O O O
make O O O O
sure O O O O
that O O O O
any O O O O
tools O O O O
developed O O O O
to O O O O
fight O O O O
the O O O O
current O O O O
pandemic O O O O
- O O O O
vaccines, O O O O
diagnostics O O O O
and O O O O
treatments O O O O
- O O O O
will O O O O
be O O O O
distributed O O O O
equitably O O O O
to O O O O
everyone O O O O
who O O O O
needs O O O O
them. O O O O
But O O O O
[more O O O O
funding O O O O
is O O O O
needed](/news/road-1-billion-vaccines-what-covid-19-dose-sharing-commitments-are-needed-g7) O O O O
to O O O O
make O O O O
the O O O O
work O O O O
of O O O O
the O O O O
ACT-Accelerator O O O O
possible. O O O O
This O O O O
explainer O O O O
was O O O O
originally O O O O
published O O O O
in O O O O
May O O O O
2020 O O O O
